BSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹50.74
- Market cap
- ₹69.62 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 14.2×Sector 34.1×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Convertible Warrants
Eiko Lifesciences allotted 1,50,000 equity shares upon conversion of warrants, receiving a balance payment of Rs. 0.62 Crore from promoter Lenus Finvest Private Limited.
- Value
- ₹0.62 Cr
- From
- Lenus Finvest Private Limited
Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited has issued a notice for its 49th Annual General Meeting scheduled for September 22, 2026, to discuss financial statements and related matters.
- Value
- ₹252.3 Cr
Eiko Lifesciences Annual Report
Eiko Lifesciences Limited has announced its 49th Annual General Meeting, scheduled for September 22, 2026. The company has also filed its Annual Report for FY 2025-26.
Other board meeting date announcements
All →Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.
National General Industries Board Meeting Date
National General Industries will hold a board meeting on November 10, 2026 to consider unaudited quarterly results. Trading window stays closed until November 16, 2026.
Vision Cinemas Board Meeting Date
Vision Cinemas Limited has intimated a board meeting on 10 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after results declaration.
Gujarat Narmada Valley Fertilizers & Chemicals Board Meeting Date
GNFC clarified its November 2, 2026 board meeting date was wrongly printed as 2025 in earlier intimations. Only the date is corrected; other information is unchanged.
VCU Data Management Board Meeting Date
VCU Data Management scheduled a board meeting for 6 November 2026. It will consider unaudited Q2 and half-year results for the period ended September 2026.